1. Regulation of metastatic potential by drug repurposing and mitochondrial targeting in colorectal cancer cells
   Shashank Mathur et al, 2024, BMC Cancer CrossRef
2. Cellular stress responses and metabolic reprogramming in cancer progression and dormancy
   Kyle K. Payne, 2022, Seminars in Cancer Biology CrossRef
3. The Role of the Microbiome on the Pathogenesis and Treatment of Colorectal Cancer
   Irene Yu et al, 2022, Cancers CrossRef
4. Effects of Vanadyl Complexes with Acetylacetonate Derivatives on Non-Tumor and Tumor Cell Lines
   Valentina Boscaro et al, 2021, Molecules CrossRef
5. High-throughput sequencing reveals twelve cell death pattern prognostic target genes as potential drug-response-associated genes in the treatment of colorectal cancer cells with palmatine hydrochloride
   Sha Luo et al, 2024, Oncologie CrossRef
6. EVT‐701 is a novel selective and safe mitochondrial complex 1 inhibitor with potent anti‐tumor activity in models of solid cancers
   Raquel Luna Yolba et al, 2021, Pharmacology Research & Perspectives CrossRef
7. Methods to Evaluate Changes in Mitochondrial Structure and Function in Cancer
   Brittany P. Rickard et al, 2023, Cancers CrossRef
8. Recent advances of mitochondrial complex I inhibitors for cancer therapy: Current status and future perspectives
   Yang Zhou et al, 2023, European Journal of Medicinal Chemistry CrossRef
9. Synthesis and biological evaluation of novel pyrazole amides as potent mitochondrial complex I inhibitors
   Yang Zhou et al, 2023, European Journal of Medicinal Chemistry CrossRef